Generation Bio Co. Shareholder Alert: Fair Price Investigation

The Ademi Firm is investigating Generation Bio Co. for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with XOMA Royalty Corporation. The transaction offers shareholders $4.2913 per share in cash plus one contingent value right per share, but the Ademi Firm alleges that the board of directors may not be fulfilling their fiduciary duties to all shareholders. The firm is specializing in shareholder litigation involving buyouts, mergers, and individual shareholder rights.